What we do Fortis Healthcare Ltd is a leading integrated healthcare provider in India, operating 27 hospitals and 400+ diagnostics centers offering specialties like cardiac care, oncology, and orthopedics. |
Founded in 1,996 |
Market share Among the largest private healthcare providers in India with significant presence in diagnostics and hospital services. |
Problem solved Provides advanced medical treatments addressing critical and chronic healthcare needs with a focus on quality and patient experience. |
Top clients or who we serve Serves patients across India with B2C focus and collaborations with insurance payors and government bodies. |
Key management Dr. Ashutosh Raghuvanshi (Managing Director & CEO) |
Our journey and innovations Since 1996, expanded from a single hospital to 27 facilities, acquired key hospitals, led diagnostics sector, and introduced advanced tech like robotic surgeries and MR LINAC. |
Where we operate Primarily India with operational presence in major states and limited international diagnostics footprint. |
Top products or what we offer Tertiary and quaternary care in cardiac, oncology, neurology, orthopedics, diagnostics via SRL and Agilus brands. |
Top brands Fortis Hospitals (#4 largest hospital chain in India), SRL Diagnostics, Agilus Diagnostics (increasing equity stake to 89.2%). |
Raw materials needed Medical consumables, pharmaceuticals, diagnostic reagents, advanced medical equipment. |
Raw materials supplier Various healthcare and pharmaceutical suppliers across India; not specifically disclosed. |
Recurring vs cyclical contribution Revenue mainly recurring from hospital operations and diagnostics services with steady growth. |
Our industry position Strong competitor with leading hospital network, robust diagnostics presence, and advanced clinical capabilities. |
Financial highlights FY25 consolidated revenue of ~Rs.7783 Cr, EBITDA Rs.1655 Cr (21.3% margin), net profit Rs.809 Cr; 11.7% CAGR in hospital revenues over 5 years. |
Geographical revenue split Majority revenues from India (~Rs.7744 Cr), minor international operations (~Rs.39 Cr). |
Order book Not applicable for healthcare services but growth driven by bed expansions and acquisitions. |
Whats driving growth Increasing ARPOB, higher occupancy rates, specialty program expansions, strategic acquisitions and diagnostics integration. |
Our future plans 3,200+ bed capacity addition by FY30; acquisitions in Punjab; enhance technology and expand diagnostics footprint. |
Our green promise Energy reduction initiatives, water metering, biomedical waste monitoring, and increased local sourcing promoting sustainability. |
Our people and values 3,184 employees with over 55% women; culture centered on clinical excellence, ethics, and patient care. |
Key challenges ahead Regulatory approvals, competitive healthcare market, managing debt levels, resolving legacy legal issues. |
Interesting facts Operates India’s first hospital with both Gamma Knife and MR-LINAC; one of few with multiple robotic surgery systems. |
Risks and strategy Facing SFIO investigations, legal risks from erstwhile promoters’ period; strategy centers on compliance, debt management, and growth. |
